Showing results (1101-1110 of 1,797) with videos related to
Sort By:
Pageof 180
Mabs|December 14, 2023
Accelerating the speed of innovative anti-tumor drugs to first-in-human trials incorporating key de-risk strategiesYuqi Wang, Quan Quan, Camille Gleason, et al.Mabs|July 19, 2024
Modulation of the high concentration viscosity of IgG1 antibodies using clinically validated Fc mutationsJoel Heisler, Daniel Kovner, Saeed Izadi, et al.Mabs|August 24, 2024
The emergence of cell-based protein arrays to test for polyspecific off-target binding of antibody therapeuticsDiana M Norden, Carmen T Navia, Jonathan T Sullivan, et al.Mabs|July 4, 2024
Engineering a tumor-selective prodrug T-cell engager bispecific antibody for safer immunotherapyAmelia C McCue, Stephen J Demarest, Karen J Froning, et al.Mabs|August 22, 2023
Monte Carlo Thompson sampling-guided design for antibody engineeringTaro Kakuzaki, Hikaru Koga, Shuuki Takizawa, et al.Mabs|July 5, 2023
Evidence of variable human Fcγ receptor-Fc affinities across differentially-complexed IgGAndrew R Crowley, Matthew R Mehlenbacher, Mohammad M Sajadi, et al.Mabs|January 4, 2019
A recycling anti-transferrin receptor-1 monoclonal antibody as an efficient therapy for erythroleukemia through target up-regulation and antibody-dependent cytotoxic effector functionsMadeline Neiveyans, Rana Melhem, Christophe Arnoult, et al.Mabs|September 17, 2020
Molecular computations of preferential interactions of proline, arginine.HCl, and NaCl with IgG1 antibodies and their impact on aggregation and viscosityTheresa K Cloutier, Chaitanya Sudrik, Neil Mody, et al.Mabs|September 24, 2020
A minimal physiologically based pharmacokinetic model to characterize colon TNF suppression and treatment effects of an anti-TNF monoclonal antibody in a mouse inflammatory bowel disease modelSongmao Zheng, Jin Niu, Brian Geist, et al.Pageof 180